A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo

Biological Psychiatry

Volumn 69, Issue 11, 2011, Pages 1075-1082

  Garza, Dahlia ^a   Murphy, Michael ^b   Tseng, Li Jung ^a   Riordan, Henry J ^b   Chatterjee, Anjan ^a  

^a PFIZER INC   (United States)

^b Medical and Scientific Affairs   (United States)

Author keywords

Neuropsychiatric; nicotine withdrawal; psychiatric; safety; smoking cessation; varenicline

Indexed keywords

PLACEBO; VARENICLINE;

ADULT; AGGRESSION; ANXIETY; ARTICLE; CHILD PSYCHIATRY; CONTROLLED STUDY; DEPRESSION; DEPRESSIVE PSYCHOSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; HAMILTON ANXIETY SCALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROPSYCHIATRY; PARTICIPANT OBSERVATION; PRIORITY JOURNAL; SIDE EFFECT; SMOKING; SMOKING CESSATION;

ADOLESCENT; ADULT; AGED; AGGRESSION; ANXIETY; BENZAZEPINES; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRRITABLE MOOD; MALE; MIDDLE AGED; NICOTINIC AGONISTS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; QUINOXALINES; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 79955773932     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.12.005     Document Type: Article

References (38)

1. D. Gonzales, S.I. Rennard, M. Nides, C. Oncken, S. Azoulay, and C.B. Billing varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial JAMA 296 2006 47 55
2. D.E. Jorenby, J.T. Hays, N.A. Rigotti, S. Azoulay, E.J. Watsky, and K.E. Williams Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 2006 56 63
3. M. Nides, C. Oncken, D. Gonzales, S. Rennard, E.J. Watsky, R. Anziano, and K.R. Reeves Smoking cessation with varenicline, a selective α4β2 nicotinic receptor partial agonist: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up Arch Intern Med 166 2006 1561 1568 (Pubitemid 44232363)
4. C. Oncken, D. Gonzales, M. Nides, S. Rennard, E. Watsky, and C.B. Billing Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation Arch Intern Med 166 2006 1571 1577 (Pubitemid 44232364)
5. M. Nakamura, A. Oshima, Y. Fujimoto, N. Maruyama, T. Ishibashi, and K.R. Reeves Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, doseresponse study with 40-week follow-up for smoking cessation in Japanese smokers Clin Ther 29 2007 1040 1056 (Pubitemid 47198885)
6. R. Niaura, J.T. Hays, D.E. Jorenby, F.T. Leone, J.E. Pappas, and K.R. Reeves The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: A randomized controlled trial Curr Med Res Opin 24 2008 1931 1941
7. S. Tonstad, P. Tønnesen, P. Hajek, K.E. Williams, C.B. Billing, K.R. Reeves Varenicline Phase 3 Study Group Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial JAMA 296 2006 64 71
8. S.T. Tsai, H.J. Cho, H.S. Cheng, C.H. Kim, K.C. Hsueh, C.B. Billing Jr, and K.E. Williams A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers Clin Ther 29 2007 1027 1039 (Pubitemid 47198884)
9. C. Wang, D. Xiao, K.P. Chan, C. Pothirat, D. Garza, and S. Davies Varenicline for smoking cessation: A placebo-controlled, randomized study Respirology 14 2009 384 392
10. Pfizer Inc Chantix (varenicline) Tablets [U.S. Precribing Information] http://www.pfizer.com/files/products/uspi-chantix.pdf 2008 Accessed March 8, 2010
11. S. Tonstad Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: A pooled analysis Drug Saf 33 2010 289 301
12. D. Gunnell, D. Irvine, L. Wise, C. Davies, and R.M. Martin Varenicline and suicidal behaviour: A cohort study based on data from the General Practice Research Database BMJ 339 2009 b3805
13. D.K. Hatsukami, J.R. Hughes, R.W. Pickens, and D. Svikis Tobacco withdrawal symptoms: An experimental analysis Psychopharmacology (Berl) 84 1984 231 236 (Pubitemid 14006578)
14. J.R. Hughes Measurement of the effects of abstinence from tobacco: A qualitative review Psychol Addict Behav 21 2007 127 137 (Pubitemid 47445172)
15. J.R. Hughes Effects of abstinence from tobacco: Valid symptoms and time course Nicotine Tob Res 9 2007 315 327 (Pubitemid 46404264)
16. J.R. Hughes Effects of abstinence from tobacco: Etiology, animal models, epidemiology, and significance: A subjective review Nicotine Tob Res 9 2007 329 339 (Pubitemid 46404265)
17. J.R. Hughes, and D. Hatsukami Signs and symptoms of tobacco withdrawal Arch Gen Psychiatry 43 1986 289 294 (Pubitemid 16052281)
18. D. Hemenway, S.J. Solnick, and G.A. Colditz Smoking and suicide among nurses Am J Public Health 83 1993 249 251 (Pubitemid 23046485)
19. J.R. Hughes Smoking and suicide: A brief overview Drug Alcohol Depend 98 2008 169 178
20. M. Miller, D. Hemenway, N.S. Bell, M.M. Yore, and P.J. Amoroso Cigarette smoking and suicide: A prospective study of 300,000 male active-duty Army soldiers Am J Epidemiol 151 2000 1060 1063 (Pubitemid 30489200)
21. M. Miller, D. Hemenway, and E. Rimm Cigarettes and suicide: A prospective study of 50,000 men Am J Public Health 90 2000 768 773 (Pubitemid 30246381)
22. World Medical Association World Medical Association Declaration of HelsinkiEthical principles for medical research involving human subjects 2008 http://www.wma.net/en/30publications/10policies/b3/index.html 2008 Accessed December 23, 2009
23. International Conference on Harmonisation The ICH process for harmonisation of guidelines http://www.ich.org 2009 Accessed December 23, 2009
24. T.F. Heatherton, L.T. Kozlowski, R.C. Frecker, and K.O. Fagerstrm The Fagerstrm Test for Nicotine Dependence: A revision of the Fagerstrm Tolerance Questionnaire Br J Addict 86 1991 1119 1127
25. M.B. First, M. Gibbon, R.L. Spitzer, J.B.W. Williams, and L.S. Benjamin User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) 1997 American Psychiatric Publishing Washington, DC
26. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders: SCID-1 Clinician Version 1997 American Psychiatric Publishing Washington, DC
27. K. Posner, M.A. Oquendo, M. Gould, B. Stanley, and M. Davies Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants Am J Psychiatry 164 2007 1035 1043 (Pubitemid 47121392)
28. A. Osman, C.L. Bagge, P.M. Gutierrez, L.C. Konick, B.A. Kopper, and F.X. Barrios The Suicidal Behaviors QuestionnaireRevised (SBQ-R): Validation with clinical and nonclinical samples Assessment 8 2001 443 454 (Pubitemid 33595964)
29. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br J Psychiatry 134 1979 382 389 (Pubitemid 9136500)
30. M. Hamilton The assessment of anxiety states by rating Br J Med Psychol 32 1959 50 55
31. H.M. Faessel, M.A. Gibbs, D.J. Clark, K. Rohrbacher, M. Stolar, and A.H. Burstein Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers J Clin Pharmacol 46 2006 1439 1448 (Pubitemid 44704204)
32. J. Levine, and N.R. Schooler SAFTEE: A technique for the systematic assessment of side effects in clinical trials Psychopharmacol Bull 22 1986 343 381 (Pubitemid 16043808)
33. B.B. Price, S. Moran, M.A. Crunican, S. Rothenberg, and H.S. Cutter Mood, primary heroin withdrawal, and acute methadone administration Int J Addict 10 1975 613 631
34. K.R. Dyer, J.M. White, D.J. Foster, F. Bochner, A. Menelaou, and A.A. Somogyi The relationship between mood state and plasma methadone concentration in maintenance patients J Clin Psychopharmacol 21 2001 78 84 (Pubitemid 32096754)
35. E.F. Coccaro, P.D. Harvey, E. Kupsaw-Lawrence, J.L. Herbert, and D.P. Bernstein Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior J Neuropsychiatry Clin Neurosci 3 1991 S44 S51
36. D.M. McNair, M. Lorr, and L. Droppleman EITS Manual for the Profile of Mood States 1992 Educational and Industrial Testing Service San Diego, CA
37. J.C. Cappelleri, A.G. Bushmakin, C.L. Baker, E. Merikle, A.O. Olufade, and D.G. Gilbert Revealing the multidimensional framework of the Minnesota Nicotine Withdrawal Scale Curr Med Res Opin 21 2005 749 760 (Pubitemid 40695297)
38. D.L. Nyenhuis, C. Yamamoto, T. Luchetta, A. Terrien, and A. Parmentier Adult and geriatric normative data and validation of the profile of mood states J Clin Psychol 55 1999 79 86 (Pubitemid 29044742)